The global Soft Mist Inhalers (SMI) Market is poised for substantial growth over the next decade. Valued at US$ 2.4 billion in 2022, the industry is projected to expand at a Compound Annual Growth Rate (CAGR) of 6.8% between 2023 and 2031. By the end of 2031, the market is expected to surpass US$ 4.4 billion, fueled by increasing respiratory disease prevalence, technological innovation, and...